Columnist Sam Kirton invites readers to join him on the way to the Pulmonary Fibrosis News Forums, where he's a moderator.

Blocking Piezo2, a protein receptor that senses mechanical forces in tissues, may be a new way to slow IPF progression, per a ...

A therapy using a patient's own proximal basal stem cells shows promise to treat idiopathic pulmonary fibrosis.

Columnist Sam Kirton and his wife go with the flow when changes are necessary, such as rescheduling a Halloween party to the advent of spring.

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Columnist Ann Reynoso says she's struggling to lose weight, but each step forward, no matter how small, is still progress.

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating its idiopathic pulmonary fibrosis (IPF) treatment bexotegrast due to safety issues. The BEACON-IPF (NCT06097260) ...